By Hugo Guzman | February 18, 2022
"The opportunity to help steer the business through this important growth phase is truly unique," said Wendy Webb Williams, Pairwise's GC and vice president of operations.
By Hugo Guzman | January 28, 2022
Jennifer Drimmer Rokovich is joining Tenaya Therapeutics as it seeks to bring to market gene therapy regimens to combat heart disease.
By Hugo Guzman | January 7, 2022
"Anyone who has spent any time with me over the last 20 years has probably heard me tell them not to be surprised when someday I climb into an RV and drive off to explore the country," Pletcher wrote on LinkedIn.
By Alaina Lancaster | September 8, 2021
Holmes' Williams & Connolly counsel painted the famed founder as a mission-driven "young CEO" whose company failed because she couldn't overcome business obstacles that she "naively underestimated" when starting the company as a 19-year-old Stanford dropout.
By Hugo Guzman | September 7, 2021
"Something about [how] the company was set up would seem to indicate that they had something to hide, and they knew it," Shehan observed.
By Alaina Lancaster | August 31, 2021
A federal judge spent the first several hours of jury selection asking whether potential jurors had been biased by best-selling books and documentaries focused on the downfall of the Theranos founder.
By Alaina Lancaster | August 27, 2021
Whether it's the most powerful law firm in the country or a solo practitioner, all lawyers need to make sure that they are documenting everything having to do with attorney client privilege and making sure their clients understand who they represent, said Smith, Gambrell & Russell's Emily Ward.
By Hugo Guzman | August 26, 2021
"Many general counsel have said [they] want more diversity, so we started researching why it hasn't happened," AbbVie's Jennifer Lagunas said.
By Hugo Guzman | July 27, 2021
The FBI reported a 400% increase in cyberattacks in 2020, and Property Casualty 360 is warning that work-from-home technologies have unexpected vulnerabilities.
By Scott Graham | May 5, 2021
The drugmakers had argued that their alleged use of a patented fluorescent protein to identify COVID-19 antibodies is protected by a safe harbor provision that covers the FDA approval process. Troutman Pepper lawyers persuaded U.S. District Judge Marilyn Huff that the safe harbor provision should not apply, at least not at this early stage of litigation.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS